Epidemiology of Sjögren syndrome

被引:37
|
作者
Beydon, Maxime [1 ]
McCoy, Sara [2 ]
Nguyen, Yann [1 ,3 ]
Sumida, Takayuki [4 ]
Mariette, Xavier [1 ,3 ]
Seror, Raphaele [1 ,3 ]
机构
[1] Univ Paris Saclay, Bicetre AP HP Hop, Dept Rheumatol, Paris, France
[2] Univ Wisconsin Madison, Dept Med, Madison, WI USA
[3] Univ Paris Saclay, Ctr Immunol Viral Infect & Autoimmune Dis, INSERM U1184, Le Kremlin Bicetre, France
[4] Univ Tsukuba, Dept Internal Med, Tsukuba, Japan
关键词
PRIMARY SJOGRENS-SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NON-HODGKIN-LYMPHOMA; QUALITY-OF-LIFE; AUTOIMMUNE RHEUMATIC-DISEASES; CLASSIFICATION CRITERIA; SICCA SYMPTOMS; CLINICAL CHARACTERISTICS; FOLLOW-UP; INTERNATIONAL-CLASSIFICATION;
D O I
10.1038/s41584-023-01057-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sjogren syndrome is a phenotypically varied autoimmune disorder that can occur alone in primary Sjogren syndrome or in association with other connective tissue diseases (CTDs), including rheumatoid arthritis, systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). The estimation of the prevalence and incidence of Sjogren syndrome varies depending on diagnostic criteria and study design, making it difficult to estimate geographical and temporal trends. Nonetheless, disease phenotype is influenced by geographical origin, which is a risk factor for systemic activity. Whether mortality in primary Sjogren syndrome is increased compared with that of the general population is not yet known, but extra-glandular manifestations, in particular lymphomas, are clear risk factors for mortality. In CTDs associated with Sjogren syndrome, lymphoma risk seems higher than that of patients with CTD alone, and there is potentially lower disease activity in SLE with Sjogren syndrome and in SSc with Sjogren syndrome than in SLE or SSc alone. In this epidemiological Review, the authors summarize the available evidence relating to the prevalence, incidence, risk factors and mortality associated with the autoimmune disorder Sjogren syndrome, with or without the co-occurrence of other connective tissue diseases. Primary Sjogren syndrome (pSS) affects mostly women, with age at disease onset as well as systemic activity varying according to geographical origin.Assessment of the prevalence of pSS varies according to study methodology, but can be estimated at between 0.01% and 0.05%, although some countries might be under-represented in this estimation.Mortality in pSS seems to be elevated predominantly in patients with extra-glandular manifestations, pulmonary involvement and non-Hodgkin lymphoma.pSS is the autoimmune disease with the most important increased risk of non-Hodgkin lymphoma, especially among patients with extra-glandular manifestations or systemic activity, low complement levels, cryoglobulinaemic vasculitis or rheumatoid factor positivity.Sjogren syndrome can be associated with other connective tissue diseases, mainly rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
引用
收藏
页码:158 / 169
页数:12
相关论文
共 50 条
  • [1] Epidemiology of Sjögren syndrome
    Maxime Beydon
    Sara McCoy
    Yann Nguyen
    Takayuki Sumida
    Xavier Mariette
    Raphaèle Seror
    Nature Reviews Rheumatology, 2024, 20 : 158 - 169
  • [2] Epidemiology of Sjögren’s Syndrome—from an Oral Perspective
    Bolstad A.I.
    Skarstein K.
    Current Oral Health Reports, 2016, 3 (4) : 328 - 336
  • [4] Sjögren syndrome
    Pilar Brito-Zerón
    Chiara Baldini
    Hendrika Bootsma
    Simon J. Bowman
    Roland Jonsson
    Xavier Mariette
    Kathy Sivils
    Elke Theander
    Athanasios Tzioufas
    Manuel Ramos-Casals
    Nature Reviews Disease Primers, 2
  • [5] Sjögren-SyndromSjögren syndrome
    A. Hansen
    T. Dörner
    Der Internist, 2010, 51 : 1267 - 1280
  • [6] Sjögren’s syndrome
    Geza Balint
    W. Watson Buchanan
    Colin A. Kean
    Walter Kean
    K. D. Rainsford
    Inflammopharmacology, 2024, 32 : 37 - 43
  • [7] Sjögren-SyndromSjögren’s syndrome
    Torsten Witte
    Zeitschrift für Rheumatologie, 2019, 78 : 511 - 517
  • [8] Sjögren-SyndromSjögren’s syndrome
    T. Witte
    Zeitschrift für Rheumatologie, 2014, 73 : 49 - 61
  • [9] Vasculopathy in sjögren's syndrome [Vaskulopathien bei sjögren-syndrom]
    Feist E.
    Hermann K.-G.A.
    Dankof A.
    Zeitschrift für Rheumatologie, 2009, 68 (4) : 305 - 311
  • [10] Vasculitis in Sjögren’s Syndrome
    R. Hal Scofield
    Current Rheumatology Reports, 2011, 13 : 482 - 488